CTIS2024-511927-32-00进行中（未招募）1 期
RP-6306-03
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
APRILIAH (Aprogen Phase III Clinical Trial to Compare Efficacy, Safety, and Immunogenicity of AP063 in Subjects with HER2+ Breast Cancer)CTIS2023-506975-83-00Aprogen Inc.720
招募中
1 期
A Phase 1, open label, randomized, 2-sequence, 2-period, crossover, single center study to evaluate the pharmacokinetics of follitropin alfa from 2 manufacturing processes, administered as a single subcutaneous 450 IU dose to pituitary-suppressed healthy premenopausal female participants.InfertilityCTIS2023-507066-91-00Merck Healthcare KGaA14
招募中
1 期
Study of GS-4528 for Adults With Solid TumorsSolid TumorsCTIS2022-502070-16-00Gilead Sciences Inc.132
进行中（未招募）
1 期
A study in healthy women to test whether BI 425809 influences the amount of a contraceptive in the bloodHealthyMedDRA version: 21.0Level: LLTClassification code: 10053349Term: Pharmacokinetic study Class: 10022891CTIS2022-500050-42-00Boehringer Ingelheim International GmbH16
进行中（未招募）
1 期
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy ParticipantsCTIS2024-512841-17-00Merck Healthcare KGaA40